Exome Asset Management »

Dr. Reddy's Laboratories shares owned by Exome Asset Management

Quarter-by-quarter ownership of Dr. Reddy's Laboratories (RDY) shares owned by Exome Asset Management from 13F filings

Historical chart of Exome Asset Management investment in Dr. Reddy's Laboratories

Tip: Access up to 7 years of quarterly data

All positions including Dr. Reddy's Laboratories held by Exome Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dr. Reddy's Laboratories by Exome Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $6.3M 86k 73.35
2023-12-31 $6.3M 90k 69.58

More positions owned by Exome Asset Management

Eli Lilly & Co. (LLY)
Dr Reddys Labs Adr (RDY)
Beigene Sponsored Adr (BGNE)
Cigna Corp (CI)
Alpine Immune Sciences (ALPN)
Tg Therapeutics (TGTX)
Avidity Biosciences Ord (RNA)
Corbus Pharmaceuticals Hldgs Com New (CRBP)
Dex (DXCM)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Celldex Therapeutics Com New (CLDX)
Geron Corporation (GERN)
Aerovate Therapeutics (AVTE)
Morphosys Sponsored Ads (MOR)
Travere Therapeutics (TVTX)

View all positions for Exome Asset Management

Top funds holding Dr. Reddy's Laboratories

BlackRock
Royal Bank of Canada
Robeco Institutional Asset Management B V
Goldman Sachs Group
Aikya Investment Management
Vanguard Group
Bank of America Corporation
Dimensional Fund Advisors
Morgan Stanley
Man Group
Lazard Asset Management
Grantham, Mayo, Van Otterloo & Co
Fisher Investments
Jpmorgan Chase & Co
Millennium Management

View all funds holding Dr. Reddy's Laboratories